drugset / Trial / NCT02158273
Medication Development in Alcoholism: Investigating PPAR Agonists
Phase 2
Completed
50 enrolled
The Scripps Research Institute
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
RandomizedParallel-groupTriple-blindOther
Summary
The primary hypotheses under test are that alcohol dependent subjects treated with fenofibrate will report decreased craving for alcohol following cue-exposure in the laboratory and report less drinking post treatment relative to placebo.
Timeline
- Start
- 2014-05
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fenofibrate | Small molecule | 145 mg | Oral |